Multisystem Langerhans Cell Histiocytosis in an infant

William Ji1, Joshua Ladner1, Aimee Rambie1

  • 1Department of Radiology, Madigan Army Medical Center, 9040A Jackson Ave, Joint Base Lewis-McChord, WA 98431, USA.

Insights

Langerhans cell histiocytosis (LCH) is a rare pediatric disease. This case study details a 5-month-old with multisystem LCH, emphasizing varied symptoms and diagnostic imaging.

Area of Science:

  • Pediatric Oncology
  • Rare Diseases
  • Histiocytosis

Background:

  • Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disorder.
  • It predominantly affects infants and young children, presenting diagnostic challenges.
  • Multisystem involvement complicates the understanding of LCH pathogenesis and management.

Observation:

  • A 5-month-old female presented with multisystem Langerhans cell histiocytosis.
  • The patient exhibited involvement across osseous, pulmonary, gastrointestinal, cutaneous, hematopoietic, and neurologic systems.
  • This case underscores the diverse clinical manifestations of LCH.

Findings:

  • Multisystem LCH presents with a wide spectrum of clinical symptoms.
  • Diagnostic imaging plays a crucial role in identifying the extent of disease.
  • Understanding risk factors and pathogenesis is key to managing LCH.

Implications:

  • This case highlights the importance of a comprehensive diagnostic approach for multisystem LCH.
  • Early and accurate diagnosis through imaging aids in timely intervention.
  • Further research into LCH pathogenesis may lead to improved therapeutic strategies.